BiomericaBMRA
13F holders, Q2 2026 (June 30)20holders +9
9new positions
0sold out
$1.76avg. 13F price*
At the end of Q2 2026, 20 institutions reported holding Biomerica Inc. (BMRA) in their 13F filings, up 9 from Q1 2026. 9 opened new positions and 0 sold out. The largest holders were HRT Financial LP ($46K), Geode Capital Management, LLC ($43K) and BlackRock, Inc. ($33K).
- Company
- Biomerica Inc.
- CUSIP
- 09061H406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $69K |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 45,815 shares bought and 32,320 shares sold, net +13,495 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| HRT Financial LP | 0.00% | New | 26,374 | $46K |
| Geode Capital Management, LLC | 0.00% | Reduce -56.6% | 24,347 | $43K |
| BlackRock, Inc. | 0.00% | No change | 18,636 | $33K |
| Vanguard Capital Management LLC | 0.00% | No change | 14,514 | $26K |
| Jane Street Group, LLC | 0.00% | New | 12,640 | $22K |
| LPL Financial LLC | 0.00% | No change | 10,849 | $19K |
| UBS Group AG | 0.00% | Add +1239.3% | 6,951 | $12K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 6,613 | $12K |
| NewEdge Advisors, LLC | 0.00% | No change | 3,603 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 238 | $419 |
| Hollencrest Capital Management | 0.00% | Reduce -75.8% | 200 | $352 |
| Harbour Investments, Inc. | 0.00% | No change | 125 | $220 |
| FMR LLC | 0.00% | New | 83 | $146 |
| IFG Advisory, LLC | 0.00% | New | 25 | $44 |
| Larson Financial Group LLC | 0.00% | New | 12 | $21 |
| Barclays PLC | 0.00% | New | 6 | $11 |
| MCF Advisors LLC | 0.00% | No change | 6 | $11 |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 3 | $5 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 2 | $4 |
| Danske Bank A/S | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is BMRA's weight in each manager's 13F, not the share of Biomerica Inc. the manager owns.